Next Article in Journal
Valency and Binding Affinity Variations Can Regulate the Multilayered Organization of Protein Condensates with Many Components
Previous Article in Journal
Pharmacological Manipulation of Early Zebrafish Skeletal Development Shows an Important Role for Smad9 in Control of Skeletal Progenitor Populations
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 11
Issue 2
10.3390/biom11020279
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Methyl Caffeate Isolated from the Flowers of Prunus persica (L.) Batsch Enhances Glucose-Stimulated Insulin Secretion

by
Dahae Lee
1,
Yutong Qi
2,
Ranhee Kim
2,
Jungbin Song
3,
Hocheol Kim
3,
Hyun Young Kim
4,
Dae Sik Jang
2,* and
Ki Sung Kang
1,*
1
College of Korean Medicine, Gachon University, Seongnam 13120, Korea
2
Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Korea
3
Department of Herbal Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea
4
Department of Food Science, Gyeongnam National University of Science and Technology, Jinju 52725, Korea
*
Authors to whom correspondence should be addressed.
Biomolecules 2021, 11(2), 279; https://doi.org/10.3390/biom11020279
Submission received: 25 January 2021 / Revised: 8 February 2021 / Accepted: 9 February 2021 / Published: 14 February 2021
Browse Figures
Versions Notes

Abstract

:
Phenolic compounds from natural products are considered effective enhancers of insulin secretion to prevent and treat type 2 diabetes (T2DM). The flowers of Prunus persica (L.) Batsch also contain many phenolic compounds. In this study, the extract of flowers of P. persica (PRPE) exhibited an insulin secretion effect in a glucose-stimulated insulin secretion (GSIS) assay, which led us to isolate and identify the bioactive compound(s) responsible for these effects. Compounds isolated from PRPE were screened for their efficacy in INS-1 rat pancreatic β-cells. Among them, caffeic acid (5), methyl caffeate (6), ferulic acid (7), chlorogenic acid (8), naringenin (11), nicotiflorin (12), and astragalin (13) isolated from PRPE increased GSIS without inducing cytotoxicity. Interestingly, the GSIS effect of methyl caffeate (6) as a phenolic compound was similar to gliclazide, an antidiabetic sulfonylurea drug. Western blot assay showed that methyl caffeate (6) enhanced the related signaling proteins of the activated pancreatic and duodenal homeobox-1 (PDX-1) and peroxisome proliferator-activated receptor-γ (PPAR-γ), but also the phosphorylation of the total insulin receptor substrate-2 (IRS-2), phosphatidylinositol 3-kinase (PI3K), and Akt, which influence β-cell function and insulin secretion. This study provides evidence that methyl caffeate (6) isolated from PRPE may aid in the management of T2DM.

1. Introduction

The incidence of type 2 diabetes (T2DM), about 90% of all diabetes cases, is constantly increasing and becoming a social problem as it is a life-threatening disease accompanied by complications such as kidney damage and slow-healing wounds [1]. T2DM is a result of pancreatic islet β-cell dysfunction and insulin resistance, which can lead to a deficiency in insulin secretion in response to glucose [2]. Pancreatic islet β-cells are characterized by basal secretion when unstimulated, in conditions of low glucose concentration, and in increased secretion when stimulated by high glucose concentration. These cells play an important role in blood glucose control by secreting insulin and accepting insulin regulation [3]. Thus, identifying compounds that act like insulin, enhance pancreatic islet β-cell regeneration, or increase insulin secretion can help to develop strategies to prevent and treat T2DM. Recently, natural products have gained attention as important resources as potential anti-T2DM bioactive compounds.
Natural ingredients have been isolated from herbal medicine with anti-T2DM properties, and their possible mechanisms have been elucidated [4,5]. Polypeptide-p isolated from Momordica charantia, a bioactive natural ingredient from herbal medicine, has been reported to act as insulin [6], and epicatechin isolated from Pterocarpus marsupium induces pancreatic islet β-cell regeneration [7]. S-methylcysteine sulfoxide isolated from Allium cepa [8], Momordicoside U isolated from Momordica charantia [9], stigmasterol-3-O-β-d-glucoside isolated from the fruit of Akebia quinata [10], formononetin isolated from Astragalus membranaceus [11], and hypoxylonol F isolated from Annulohypoxylon annulatum [12] have been reported as bioactive compounds that increase insulin secretion from pancreatic islet β-cells. These bioactive natural ingredients that increase insulin secretion also enhance the expression of proteins related to the regulation of pancreatic β-cell survival and function, such as peroxisome proliferator-activated receptor-γ (PPARγ), insulin receptor substrate-2 (IRS-2), phosphatidylinositol 3-kinase (PI3K), Akt, and pancreatic and duodenal homeobox-1 (PDX-1).
The flower of Prunus persica (L.) Batsch has long been used in Chinese herbal medicine to treat skin disorders [13]. In previous studies based on this, the flower of P. persica has shown a protective effect from ultraviolet radiation and an inhibitory effect on melanogenesis on skin [13,14,15]. However, antidiabetic effects have yet to be demonstrated for its extract and its isolated compounds. The flowers of P. persica contain phenolic compounds, which in many plants have been reported to possess antidiabetic effects. Caffeic acid [16,17], naringenin [17], ferulic acid [18], astragalin [19], and chlorogenic acid have been reported to increase insulin secretion [20]. It has been reported that methyl caffeate induces pancreatic islet β-cell regeneration [21].
These previous studies propose that extracts of P. persica (PRPE) and phenolic compounds isolated from it are likely to be effective in increasing insulin secretion from pancreatic β cells.
In the current study, we found that PRPE showed an insulin secretion effect in a screening test, which led us to isolate and identify the bioactive compound(s) responsible for these effects. Next, a glucose-stimulated insulin secretion (GSIS) assay was conducted on INS-1 rat pancreatic β-cells to determine which of the isolated compounds contributed to the insulin secretion effect. After the preliminary screening, we focused on methyl caffeate, which showed similar effects to an antidiabetic sulfonylurea drug (gliclazide) and evaluated how it affects protein expression, including that of PPARγ, IRS-2, PI3K, Akt, and PDX-1.

2. Materials and Methods

2.1. General Experimental Procedures

NMR spectra were obtained using a 500 MHz (JEOL, Tokyo, Japan). Optical rotations were evaluated on a Jasco P-2000 polarimeter (JASCO, Tokyo, Japan) using a 10-cm microcell. Thin layer chromatography (TLC) analyses were performed on silica gel 60 F254S (Merck, Kenilworth, NJ, USA) and RP-18 F254S (Merck) plates. The compounds were visualized by dipping the plates into 20% (v/v) H2SO4 reagent (Aldrich, St. Louis, MI, USA) and then heated at 123 °C for 10–15 min. Diaion HP-20 (Mitsubishi, Tokyo, Japan) and Sephadex LH-20 (Amersham Pharmacia Biotech, Amersham, UK) were used for column chromatography. Flash chromatography was performed using a flash purification system (Combi Flash Rf; Teledyne Isco, Lincoln, NE, USA) with pre-packed cartridges, Redi Sep-C18 (26 and 43 g; Teledyne Isco). All solvents used for the chromatographic separations were distilled before use.

2.2. Plant Material

The dried flowers of P. persica Batsch (Rosaceae) were purchased from a Chinese herbal market (Xian, Shaanxi province, China) and authenticated by one of the authors H.K. A voucher specimen (PRPE-2018) of the raw material was deposited in the Laboratory of Natural Product Medicine, College of Pharmacy, Kyung Hee University, Seoul, Korea.

2.3. Extraction and Isolation

The dried flowers (100.0 g) of P. persica were extracted twice with distilled water at 100 °C for 2 h, and the solvent was evaporated in vacuo at 45 °C to obtain the hot water extract (PRPE, 23.5 g), which was then fractionated using Diaion HP-20 column chromatography (CC) (ϕ 4.6 × 32.3 cm, acetone-H2O = 40:60 to 60:40 v/v) to obtain eight fractions (F1–F8).
Fraction F1 (21.1 g) was separated by Sephadex LH-20 CC (ϕ 4.6 × 32.0 cm), with acetone-H2O (0:100 to 40:60 v/v), to obtain 10 subfractions (F1-1–F1-10). Subfraction F1-4 was fractionated using Sephadex LH-20 CC (ϕ 3.7 × 49.1 cm, 40% acetone) into compound 8 (150.7 mg) and 13 subfractions (F1-4-1–F1-4-13). Subfractions F1-4-5 was subjected to flash CC with Redi Sep-C18 cartridge (43 g, MeOH-H2O = 0:100 to 40:60 v/v) and produced compounds 1 (459.8 mg) and 9 (22.7 mg). Compound 2 (19.6 mg) was isolated by flash CC using a Redi Sep-C18 cartridge (26 g, acetonitrile-H2O = 0:100 to 30:70 v/v) from subfraction F1-4-4. Subfraction F1-4-8 was fractionated using a Redi Sep-C18 cartridge (43 g, acetonitrile-H2O = 0:100 to 40:60 v/v) to produce compounds 3 (99.3 mg) and 4 (125.6 mg). Compounds 5 (22.9 mg) and 6 (9.0 mg) were separated by Sephadex LH-20 CC (ϕ 3.9 × 89.0 cm, 40% acetone) from subfraction F1-3. Subfraction F1-2 was fractionated further using Sephadex LH-20 CC (ϕ 3.7 × 49.1 cm, 40% acetone) and was divided into five subfractions (F1-2-1–F1-2-5). Compound 15 (10.1 mg) was purified using a Redi Sep-C18 cartridge (43 g, MeOH-H2O = 0:100 to 20:80 v/v) from subfraction F1-2-5.
Fraction F2 (567.9 mg) was separated into 11 subfractions (F2-1–F2-11) using Sephadex LH-20 CC (ϕ 2.5 × 61.8 cm, MeOH-H2O = 80:20. Subfraction F2-5 was subjected to flash CC with Redi Sep-C18 cartridge (26 g, MeOH-H2O = 35:65 to 45:55 v/v) and generated compounds 7 (8.3 mg) and 10 (16.7 mg). Subfraction F2-5 was separated using a flash chromatographic system with a Redi Sep-C18 cartridge (26 g, MeOH-H2O = 35:65 to 45:55 v/v) to give compound 12 (4.3 mg). Compound 13 (13.3 mg) was purified from subfraction F2-8 using a Redi Sep-C18 column (26 g, MeOH-H2O = 0:0 to 45:55 v/v). Subfraction F2-9 was chromatographed on a flash chromatographic system with a Redi Sep-C18 cartridge (26 g, MeOH-H2O = 35:65 to 45:55 v/v) to produce compound 14 (20.9 mg).
Fraction F6 (112.3 mg) was further fractionated using a Sephadex LH-20 column (ϕ 2.5× 61.0 cm, 80% MeOH) to isolate compound 11 (15.1 mg).

2.4. Cell Culture

INS-1 cells from an immortalized rat insulinoma pancreatic β-cell line were purchased from Biohermes (Shanghai, China). INS-1 cells were cultured in a monolayer format in a Roswell Park Memorial Institute (RPMI) 1640 medium (Cellgro, Manassas, VA, USA) supplemented with 1% penicillin/streptomycin (Invitrogen Co., Grand Island, NY, USA), 10% fetal bovine serum (FBS), 2 mM L-glutamine, 0.05 mM 2-mercaptoethanol, 11 mM D-glucose, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and 1 mM sodium pyruvate in a humidified atmosphere at 37 °C containing 5% CO2.

2.5. Cell Viability

The Ez-Cytox cell viability assay kit (Daeil Lab Service Co., Seoul, Korea) was used to determine the cytotoxicity concentration of PRPE and compounds 1–15 on INS-1 cells before their use in the glucose-stimulated insulin secretion (GSIS) assay. Compounds 1–15 were dissolved in dimethyl sulfoxide (DMSO) at a concentration of 100 mM. This was used as a stock solution, further diluted 100 times or more in a cell culture medium, and 0.5% DMSO was used as a solvent control in the untreated cells. INS-1 cells were seeded at a density of 10,000 cells per well in 96-well plates for 24 h. Afterwards, INS-1 cells were treated with different concentrations of PRPE and compounds 1–15 for 24 h. Cell viability was determined by incubating INS-1 cells in 10% (v/v) Ez-Cytox reagent for 2 h. Thereafter, the optical density (OD) at 450 nm was measured using a microplate reader (PowerWave XS, Bio-Tek Instruments, Winooski, VT, USA).

2.6. Glucose-Stimulated Insulin Secretion Assay

A rat insulin ELISA kit (Gentaur, Shibayagi Co. Ltd., Gunma, Shibukaw, Japan) was used to determine the insulin secretory function of PRPE and compounds 1–15 on INS-1 cells. INS-1 cells were seeded at a density of 400,000 cells per well in 12-well plates for 24 h. Afterwards, INS-1 cells were first incubated in a Krebs–Ringer bicarbonate buffer (KRB, pH 7.4) and starved for 1 h. The KRB was then removed and preincubated with PRPE, compounds 1–15, or gliclazide for 30 min, then stimulated for 1 h with KBR with low glucose (3.3 mM) or high glucose (16.7 mM), respectively, as an INS-1 cell stimulant. The KRB was collected, and the insulin concentration in KRB was measured using a rat insulin ELISA kit in accordance with the manufacturer’s instructions. The optical density at 450 nm was measured using a microplate reader (PowerWave XS, Bio-Tek Instruments, Winooski, VT, USA). The glucose stimulation index (GSI) was calculated as follows: GSI = insulin level in high glucose (16.7 mM)/insulin level in low glucose (3.3 mM).

2.7. Western Blot Analysis

Western blot analysis was performed to determine the effect of methyl caffeate (6) on protein expression related to pancreatic β-cell metabolism. INS-1 cells were seeded at a density of 800,000 cells/well in 6-well plates for 24 h, then treated with different concentrations of methyl caffeate (6) for 24 h and finally collected. Total protein was extracted in cold RIPA buffer (Cell Signaling, Danvers, MA, USA) containing 1 mM phenylmethylsulfonyl fluoride. Protein samples were separated on a 10% sodium dodecyl sulfate polyacrylamide gel. The separated proteins were transferred onto polyvinylidene difluoride membranes. The membrane was incubated with primary antibodies against PDX-1, Phospho-IRS2 (P-IRS2) (Ser731), IRS-2, Phospho-PI3K (P-PI3K), PI3K, phospho-Akt (P-Akt) (Ser473), Akt, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) overnight at 4 °C, then incubated with horseradish peroxidase (HRP)-conjugated anti-rabbit secondary antibodies at room temperature for 1 h. The target protein band on the membrane was developed using ECL Plus Western blotting detection reagents (GE Healthcare, Little Chalfont, UK), and the immunoreactive bands were visualized using a chemiluminescence system (FUSION Solo, PEQLAB Biotechnologie GmbH, Erlangen, Germany).

2.8. Statistical Analysis

All experiments were performed in triplicates. All analyses were performed using SPSS Statistics ver. 19.0 (SPSS Inc., Chicago, IL, USA). Nonparametric comparisons of samples were conducted using the Kruskal–Wallis test to analyze the results. A value of p < 0.05 was considered to be statistically significant.

3. Results

3.1. Identification of Compounds 1–15

The chemical structures of the isolated compounds were identified by analysis of spectroscopic data (1H, 13C, and 2D NMR) measurements and a comparison with reported data (Table 1 and Figure 1).

3.2. Effects of PRPE and Compounds 1–15 on Glucose-Stimulated Insulin Secretion

PRPE and compounds 1–15 were tested for their effect on cell viability to select the non-toxic concentration to be used in the glucose-stimulated insulin secretion (GSIS) assay and did not show any toxicity at any concentration (Figure 2).
As shown in Figure 3, PRPE, compounds 5–8, and compounds 11–13 increased GSIS (ng/mL per 400,000 cells). GSIS was expressed as the GSI. Fold change was set at 1 for control cells. As shown in Figure 4A, PRPE increased the GSI at concentrations of 5 and 10 μg/mL. At that concentration, the values of GSI were 2.94 ± 0.13 and 3.11 ± 0.43, respectively. This result indicated that PRPE contains compounds with GSIS activity. GSI values were: 2.39 ± 0.32 and 3.82 ± 0.23 for caffeic acid (5) at concentrations of 5 and 10 μM, respectively (Figure 4F); 4.01 ± 0.08 and 5.34 ± 0.06 for methyl caffeate (6) at a concentration of 5 and 10 μM, respectively (Figure 4G); 4.16 ± 0.18 for ferulic acid (7) at a concentration of 10 μM (Figure 4H); 4.05 ± 0.04 for chlorogenic acid (8) at a concentration of 10 μM (Figure 4I); 2.81 ± 0.29 and 4.75 ± 0.29 for naringenin (11) at concentrations of 5 and 10 μM, respectively (Figure 4L); 3.59 ± 0.07 for nicotiflorin (12) at a concentration of 10 μM (Figure 4M); and 3.71 ± 0.02 for astragalin (13) at a concentration of 10 μM (Figure 4N). Among these compounds, the GSI of methyl caffeate (6) was the highest, and its GSIS activity was similar to that of gliclazide (6.01 ± 0.16 at a concentration of 10 μM, Figure 4Q): methyl caffeate (6) was selected as the subject of further mechanistic studies.

3.3. Effect of Methyl Caffeate (6) on the Protein Expression of PPARγ, P-IRS-2, IRS-2, P-PI3K, PI3K, P-Akt (Ser473), Akt, and PDX-1

To explore the underlying influence of methyl caffeate (6) on glucose-stimulated insulin secretion in INS-1 cells, the expression of proteins related to pancreatic β-cell metabolism was analyzed. As shown in Figure 5A, 10 μM methyl caffeate (6) increased the relative abundances of peroxisome proliferator activated receptor γ (PPARγ), phospho-insulin receptor substrate-2 (P-IRS-2) (Ser731), phospho-phosphatidylinositol 3-kinase (P-PI3K), phospho-Akt (P-Akt) (Ser473), and pancreatic and duodenal homeobox-1 (PDX-1) proteins. The bar graphs illustrate the ratio of PPARγ, P-IRS-2, P-PI3K, P-Akt (Ser473), and PDX-1 expression normalized to their corresponding GAPDH expression (Figure 5B–F). These results suggest that the effect of methyl caffeate (6) enhances the expression of proteins related to pancreatic β-cell metabolism.

4. Discussion

The results of this study indicated that PRPE increased GSIS, which led us to isolate and identify the bioactive compound(s) responsible for these effects. Among the isolated compounds, caffeic acid (5), methyl caffeate (6), ferulic acid (7), chlorogenic acid (8), naringenin (11), nicotiflorin (12), and astragalin (13) increased GSIS. Our results are in agreement with previous studies, which showed that caffeic acid (5) [16,17], ferulic acid (7) [18], chlorogenic acid (8), naringenin (11) [17], and astragalin (13) [19] have been reported to increase insulin secretion [20]. Whereas each compound was previously isolated from a different plant, in our study, PRPE with GSIS effect contained all these compounds, with the addition of methyl caffeate (6), chlorogenic acid (8), and nicotiflorin (12), for which no GSIS effect was reported.
Interestingly, methyl caffeate (6) has a better effect than its free acid form, caffeic acid (5). Several studies on the biological activities of methyl caffeate (6) have reported its neuroprotective [36], anticancer [37], antioxidant [38], and anti-inflammatory effects [39] as well as antimicrobial and antimycobacterial activities [40]. Additionally, the induction of pancreatic islet β-cell regeneration by methyl caffeate (6) has also become clear [21], as its oral administration improved glucose tolerance in rats. It has been speculated, but still not proved, that this effect is mediated through insulin secretion from pancreatic islet β-cells. In this study, the GSIS effect of methyl caffeate (6) was similar to that of gliclazide, an antidiabetic sulfonylurea drug. Based on the GSIS assay, we have shown the possible GSIS activity of methyl caffeate (6) GSIS by modulating cell secretory capacity. These findings distinguish our study from previously reported antidiabetic effects of methyl caffeate (6).
In this study, Western blot analysis was performed to determine the effect of methyl caffeate (6) on protein expression related to pancreatic β-cell metabolism, such as PPARγ, IRS-2, PI3K, Akt, and PDX-1. According to published studies, synthetic ligands for PPAR-γ influence GSIS, as PPAR-γ activation upregulates the GPR40 receptor in INS-1 cells [41,42]. In addition, the gene expression of pancreatic β-cells is upregulated through PPAR-γ activation [41]. PPAR-γ agonists have been shown to have a direct effect on improving pancreatic β-cell survival and function [43]. An increase in insulin secretion induced by rosiglitazone, a thiazolidinedione antihyperglycemic agent, is mediated through the PPAR-γ pathway in INS-1 cells [44]. Our study also showed a clear increase in the expression level of PPAR-γ in INS-1 cells treated with methyl caffeate (6).
IRS-2 closely regulates pancreatic β-cell growth and development [45]. Deletion of IRS-2 in mice leads to pancreatic β-cell mass [46]. Because β-cell mass grows into adulthood to meet increased insulin demand, adequate islet mass is essential for insulin secretion [47]. In addition, IRS-2 activates Akt in a PI3K-dependent manner. The PI3K/Akt pathway has been shown to regulate early-phase insulin secretion [48], β-cell mass, and function. The expression of Akt is also required for β-cell regeneration [49]. Recent evidence has demonstrated that rosiglitazone enhances GSIS in the pancreas of rats through PI3K activation [50]. A previous study reported that silibinin, a flavonoid, can improve β-cell functionality and increase GSIS through the upregulation of IRS-2 and PDX-1 [51]. Studies have further indicated that imeglimin derivatives promote GSIS, which is associated with an overexpressed IRS-2, while promoting Akt [52]. Our study also showed that methyl caffeate (6) significantly increased the expression of IRS-2, PI3K, and Akt in treated INS-1 cells.
Another important role of the IRS-2/PI3K/Akt pathway is the regulation of nuclear translocation of endogenous PDX-1. A previous study demonstrated that the key gene involved in β-cell functionality and insulin synthesis is PDX-1, a β-cell transcription factor. In IRS-2 knockout mice, transgenic expression of PDX-1 restores β-cell function, including insulin secretion [53]. In agreement with the positive effects of overexpressed PDX-1 on GSIS by treatment with resveratrol, a polyphenolic compound [54], the present study found that the protein expression of PDX-1 increased after treatment with methyl caffeate (6) in the same pattern as the protein expression of IRS-2, PI3K, and Akt. Therefore, the potentiation effect of methyl caffeate (6) on the GSIS might be explained by the upregulation of PPARγ and PDX-1 via the IRS-2 signaling pathways in INS-1 cells, which play an important role in β-cell function for insulin-secretory capacity to promote GSIS.

5. Conclusions

Our results showed that PRPE and caffeic acid (5), methyl caffeate (6), ferulic acid (7), chlorogenic acid (8), naringenin (11), nicotiflorin (12), and astragalin (13) isolated from PRPE enhanced GSIS in INS-1 cells. Interestingly, the GSIS effect of methyl caffeate (6) was similar to that of gliclazide, an antidiabetic sulfonylurea drug. INS-1 rat pancreatic β-cells treated with caffeic acid (5) also enhanced the induction of PPARγ and PDX-1 via the IRS-2 signaling pathways related to survival and function of pancreatic β-cells. Ultimately, these promising findings highlighted caffeic acid (5) isolated from PRPE as a possible drug candidate to treat T2DM after its promising results in vivo. Despite these findings, further investigations are needed to check whether methyl caffeate (6) can increase insulin gene expression or insulin content, and more studies are needed to prove the effect of methyl caffeate (6) in animal models for studies of T2DM.

Author Contributions

Conceptualization, K.S.K. and D.S.J.; validation, Y.Q., R.K. and J.S.; formal analysis, D.L., H.Y.K. and H.K.; data curation, D.L. and H.K.; writing—original draft preparation, D.L. and D.S.J.; writing—review and editing, D.L. and K.S.K.; supervision, D.S.J. and K.S.K.; project administration, D.L. and K.S.K.; funding acquisition, D.S.J. and K.S.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2019R1F1A1059173, 2020R1A6A3A01100467). This research was also supported by a grant from the Bio-Synergy Research Project (NRF-2015M3A9C4070483) of the Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea (NRF).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Deshpande, A.D.; Harris-Hayes, M.; Schootman, M. Epidemiology of Diabetes and Diabetes-Related Complications. Phys. Ther. 2008, 88, 1254–1264. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Rorsman, P.; Ashcroft, F.M. Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men. Physiol. Rev. 2018, 98, 117–214. [Google Scholar] [CrossRef] [PubMed]
  3. Leibiger, I.B.; Leibiger, B.; Berggren, P.-O. Insulin Signaling in the Pancreatic β-Cell. Annu. Rev. Nutr. 2008, 28, 233–251. [Google Scholar] [CrossRef] [PubMed]
  4. Xu, L.; Li, Y.; Dai, Y.; Peng, J. Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mecha-nisms. Pharmacol. Res. 2018, 130, 451–465. [Google Scholar] [CrossRef]
  5. Tran, N.; Pham, B.; Le, L. Bioactive Compounds in Anti-Diabetic Plants: From Herbal Medicine to Modern Drug Discovery. Biology 2020, 9, 252. [Google Scholar] [CrossRef]
  6. Paul, A.; Raychaudhuri, S.S. Medicinal uses and molecular identification of two Momordica charantia varieties-a review. J. Biol. 2010, 6, 43–51. [Google Scholar]
  7. Ahmad, F.; Khalid, P.; Khan, M.M.; Rastogi, A.K.; Kidwai, J.R. Insulin like activity in (−) epicatechin. Acta Diabetol. Lat. 1989, 26, 291–300. [Google Scholar] [CrossRef]
  8. Kumari, K.; Augusti, K.T. Antidiabetic and antioxidant effects of S-methyl cysteine sulfoxide isolated from onions (Allium cepa Linn) as compared to standard drugs in alloxan diabetic rats. Indian J. Exp. Boil. 2002, 40, 1005–1009. [Google Scholar]
  9. Lee, S.Y.; Eom, S.H.; Kim, Y.K.; Park, N.I.; Park, S.U. Cucurbitane-type triterpenoids in Momordica charantia Linn. J. Med. Plant Res. 2009, 3, 1264–1269. [Google Scholar]
  10. Lee, D.; Lee, J.S.; Sezirahiga, J.; Kwon, H.C.; Jang, D.S.; Kang, K.S. Bioactive Phytochemicals Isolated from Akebia quinata Enhances Glucose-Stimulated Insulin Secretion by Inducing PDX-1. Plants 2020, 9, 1087. [Google Scholar] [CrossRef]
  11. Lee, D.; Lee, D.H.; Choi, S.; Lee, J.S.; Jang, D.S.; Kang, K.S. Identification and Isolation of Active Compounds from Astragalus membranaceus that Improve Insulin Secretion by Regulating Pancreatic β-Cell Metabolism. Biomolecules 2019, 9, 618. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Lee, D.; Hwang, B.S.; Choi, P.; Kim, T.; Kim, Y.; Song, B.G.; Yamabe, N.; Hwang, G.S.; Kang, K.S.; Ham, J. Hypoxylonol F Isolated from Annulohypoxylon annulatum Improves Insulin Secretion by Regulating Pancreatic β-cell Metabolism. Biomolecules 2019, 9, 335. [Google Scholar] [CrossRef] [Green Version]
  13. Heo, M.Y.; Jo, B. The extract of the flowers of Prunus persica, a new cosmetic ingredient, protects against solar ultra-violet-induced skin damage in vivo. J. Cosmet. Sci. 2002, 53, 27–34. [Google Scholar]
  14. Kwak, C.S.; Yang, J.; Shin, C.-Y.; Chung, J.H. Topical or oral treatment of peach flower extract attenuates UV-induced epidermal thickening, matrix metalloproteinase-13 expression and pro-inflammatory cytokine production in hairless mice skin. Nutr. Res. Pr. 2018, 12, 29–40. [Google Scholar] [CrossRef]
  15. Murata, K.; Takahashi, K.; Nakamura, H.; Itoh, K.; Matsuda, H. Search for Skin-whitening Agent from Prunus Plants and the Molecular Targets in Melanogenesis Pathway of Active Compounds. Nat. Prod. Commun. 2014, 9, 185–188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Yusuf, M.; Nasiruddin, M.; Sultana, N.; Badruddeen; Akhtar, J.; Khan, M.I.; Ahmad, M. Regulatory Mechanism of Caffeic acid on glucose Metabolism in Diabetes. Res. J. Pharm. Technol. 2019, 12, 4735. [Google Scholar] [CrossRef]
  17. Bhattacharya, S.; Oksbjerg, N.; Young, J.F.; Jeppesen, P.B. Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells. Diabetesobes. Metab. 2013, 16, 602–612. [Google Scholar] [CrossRef]
  18. Narasimhan, A.; Chinnaiyan, M.; Karundevi, B. Ferulic acid exerts its antidiabetic effect by modulating insulin-signalling molecules in the liver of high-fat diet and fructose-induced type-2 diabetic adult male rat. Appl. Physiol. Nutr. Metab. 2015, 40, 769–781. [Google Scholar] [CrossRef] [PubMed]
  19. Rey, D.; Sulis, P.M.; Fernandes, T.A.; Gonçalves, R.; Frederico, M.J.S.; Costa, G.M.; Aragon, M.; Ospina, L.F.; Silva, F.R.M.B. Astragalin augments basal calcium influx and insulin secretion in rat pancreatic islets. Cell Calcium 2019, 80, 56–62. [Google Scholar] [CrossRef]
  20. Zuñiga, L.Y.; La Mora, M.C.A.-D.A.-D.; Gonzalez-Ortiz, M.; Ramos-Núñez, J.L.; Martinez-Abundis, E. Effect of Chlorogenic Acid Administration on Glycemic Control, Insulin Secretion, and Insulin Sensitivity in Patients with Impaired Glucose Tolerance. J. Med. Food 2018, 21, 469–473. [Google Scholar] [CrossRef]
  21. Gandhi, G.R.; Ignacimuthu, S.; Paulraj, M.G.; Sasikumar, P. Antihyperglycemic activity and antidiabetic effect of methyl caffeate isolated from Solanum torvum Swartz. fruit in streptozotocin induced diabetic rats. Eur. J. Pharmacol. 2011, 670, 623–631. [Google Scholar] [CrossRef]
  22. Nahrstedt, A.; Rockenbach, J. Occurrence of the cyanogenic glucoside prunasin and II corresponding mandelic acid amide glucoside in Olinia species (oliniaceae). Phytochemistry 1993, 34, 433–436. [Google Scholar] [CrossRef]
  23. Lee, S.Y.; Kim, K.H.; Lee, I.K.; Lee, K.H.; Choi, S.U.; Lee, K.R. A new flavonol glycoside from Hylomecon vernalis. Arch. Pharm. Res. 2012, 35, 415–421. [Google Scholar] [CrossRef]
  24. Yashunsky, D.V.; Kulakovskaya, E.V.; Kulakovskaya, T.V.; Zhukova, O.S.; Kiselevskiy, M.V.; Nifantiev, N.E. Synthesis and Biological Evaluation of Cyanogenic Glycosides. J. Carbohydr. Chem. 2015, 34, 460–474. [Google Scholar] [CrossRef]
  25. Rahman, W.; Ishratullah, K.; Wagner, H.; Seligmann, O.; Chari, V.; Österdahl, B.-G. Prunin-6″-O-p-coumarate, a new acylated flavanone glycoside from Anacardium occidentale. Phytochemistry 1978, 17, 1064–1065. [Google Scholar] [CrossRef]
  26. Deol, B.; Ridley, D.; Simpson, G. Asymmetric reductinon of carbonyl compounds by yeast. II. Preparation of optically active α- and β-hydroxy carboxylic acid derivatives. Aust. J. Chem. 1976, 29, 2459–2467. [Google Scholar] [CrossRef]
  27. Tisserant, L.P.; Hubert, J.; Lequart, M.; Borie, N.; Maurin, N.; Pilard, S.; Jeandet, P.; Aziz, A.; Renault, J.H.; Nuzillard, J.M.; et al. C NMR and LC-MS profiling of stilbenes from elicited grapevine hairy root cultures. J. Nat. Prod. 2016, 79, 2846–2855. [Google Scholar] [CrossRef]
  28. Exarchou, V.; Troganis, A.; Gerothanassis, I.P.; Tsimidou, M.; Boskou, D. Identification and quantification of caffeic and rosmarinic acid in complex plant extracts by the use of variable-temperature two-dimensional nuclear magnetic resonance spectroscopy. J. Agric. Food Chem. 2001, 49, 2–8. [Google Scholar] [CrossRef]
  29. Kazuma, K.; Noda, N.; Suzuki, M. Malonylated flavonol glycosides from the petals of Clitoria ternatea. Phytochemistry 2003, 62, 229–237. [Google Scholar] [CrossRef]
  30. Ogihara, K.; Kuwae, M.; Suzuka, T.; Higa, M. Constituents from the fruits of Messerschmidia argentea (4). Bull. Fac. Sci. Univ. Ryukyus 2012, 93, 47–54. [Google Scholar]
  31. Chiang, H.-C.; Lo, Y.-J.; Lu, F.-J. Xanthine Oxidase Inhibitors from the Leaves of Alsophila Spinulosa(HOOK) Tryon. J. Enzym. Inhib. 1994, 8, 61–71. [Google Scholar] [CrossRef]
  32. Yawadio, R.; Tanimori, S.; Morita, N. Identification of phenolic compounds isolated from pigmented rices and their al-dose reductase inhibitory activities. Food Chem. 2007, 101, 1616–1625. [Google Scholar] [CrossRef]
  33. De Almeida, A.P.; Miranda, M.M.F.S.; Simoni, I.C.; Wigg, M.D.; Lagrota, M.H.C.; Costa, S.S. Flavonol monoglycosides isolated from the antiviral fractions of Persea americana (Lauraceae) leaf infusion. Phytother. Res. 1998, 12, 562–567. [Google Scholar] [CrossRef]
  34. Suárez-Quiroz, M.L.; Campos, A.A.; Alfaro, G.V.; Gonzalez-Rios, O.; Villeneuve, P.; Figueroa-Espinoza, M.-C. Isolation of green coffee chlorogenic acids using activated carbon. J. Food Compos. Anal. 2014, 33, 55–58. [Google Scholar] [CrossRef]
  35. Mantsch, H.H.; Smith, I.C.P. A Study of Solvent Effects on the 13C Nuclear Magnetic Resonance Spectra of Cholesterol, Pyridine, And Uridine. Can. J. Chem. 1973, 51, 1384–1391. [Google Scholar] [CrossRef] [Green Version]
  36. Jantas, D.; Chwastek, J.; Malarz, J.; Stojakowska, A.; Lasoń, W. Neuroprotective effects of methyl caffeate against hydrogen peroxide-induced cell damage: Involvement of caspase 3 and cathepsin d inhibition. Biomolecules 2020, 10, 1530. [Google Scholar] [CrossRef]
  37. Balachandran, C.; Emi, N.; Arun, Y.; Yamamoto, Y.; Ahilan, B.; Sangeetha, B.; Duraipandiyan, V.; Inaguma, Y.; Okamoto, A.; Ignacimuthu, S.; et al. In vitro anticancer activity of methyl caffeate isolated from Solanum torvum Swartz. fruit. Chem. Interact. 2015, 242, 81–90. [Google Scholar] [CrossRef] [PubMed]
  38. Urbaniak, A.; Kujawski, J.; Czaja, K.; Szelag, M. Antioxidant properties of several caffeic acid derivatives: A theoretical study. C. R. Chim. 2017, 20, 1072–1082. [Google Scholar] [CrossRef]
  39. Shin, K.-M.; Kim, I.-T.; Park, Y.-M.; Ha, J.; Choi, J.-W.; Park, H.-J.; Lee, Y.S.; Lee, K.-T. Anti-inflammatory effect of caffeic acid methyl ester and its mode of action through the inhibition of prostaglandin E2, nitric oxide and tumor necrosis factor-α production. Biochem. Pharmacol. 2004, 68, 2327–2336. [Google Scholar] [CrossRef] [PubMed]
  40. Balachandran, C.; Duraipandiyan, V.; Al-Dhabi, N.A.; Balakrishna, K.; Kalia, N.P.; Rajput, V.S.; Khan, I.A.; Ignacimuthu, S. Antimicrobial and Antimycobacterial Activities of Methyl Caffeate Isolated from Solanum torvum Swartz. Fruit. Indian J. Microbiol. 2012, 52, 676–681. [Google Scholar] [CrossRef] [Green Version]
  41. Kim, H.-S.; Hwang, Y.-C.; Koo, S.-H.; Park, K.S.; Lee, M.-S.; Kim, K.-W.; Lee, M.-K. PPAR-γ activation increases insulin se-cretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells. PLoS ONE 2013, 8, e50128. [Google Scholar]
  42. Santini, E.; Fallahi, P.; Ferrari, S.M.; Masoni, A.; Antonelli, A.; Ferrannini, E. Effect of PPAR-γ activation and inhibition on glucose-stimulated insulin release in INS-1e cells. Diabetes 2004, 53, S79–S83. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Kono, T.; Ahn, G.; Moss, D.R.; Gann, L.; Zarain-Herzberg, A.; Nishiki, Y.; Fueger, P.T.; Ogihara, T.; Evans-Molina, C. PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyper-glycemic and cytokine stress. Mol. Endocrinol. 2012, 26, 257–271. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Zhang, K.; Yuan, Q.; Xie, J.; Yuan, L.; Wang, Y. PPAR-γ activation increases insulin secretion independent of CASK in INS-1 cells. Acta Biochim. et Biophys. Sin. 2019, 51, 715–722. [Google Scholar] [CrossRef]
  45. Lingohr, M.K.; Briaud, I.; Dickson, L.M.; McCuaig, J.F.; Alárcon, C.; Wicksteed, B.L.; Rhodes, C.J. Specific Regulation of IRS-2 Expression by Glucose in Rat Primary Pancreatic Islet β-Cells. J. Biol. Chem. 2006, 281, 15884–15892. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Iglesias-Osma, M.C.; Blanco, E.J.; Carretero-Hernandez, M.; Catalano-Iniesta, L.; Sanchez-Robledo, V.; Garcia-Barrado, M.J.; Vicente-Garcia, T.; Burks, D.J.; Carretero, J. The influence of the lack of insulin receptor substrate 2 (IRS2) on the thyroid gland. Sci. Rep. 2019, 9, 5673. [Google Scholar] [CrossRef] [Green Version]
  47. Cerf, M.E. Beta Cell Dysfunction and Insulin Resistance. Front. Endocrinol. 2013, 4, 37. [Google Scholar] [CrossRef] [Green Version]
  48. Cheng, K.K.; Lam, K.S.; Wu, D.; Wang, Y.; Sweeney, G.; Hoo, R.L.; Zhang, J.; Xu, A. APPL1 potentiates insulin secretion in pancreatic β cells by enhancing protein kinase Akt-dependent expression of SNARE proteins in mice. Proc. Natl. Acad. Sci. USA 2012, 109, 8919–8924. [Google Scholar] [CrossRef] [Green Version]
  49. Elghazi, L.; Rachdi, L.; Weiss, A.; CrasMéneur, C.; BernalMizrachi, E. Regulation of βcell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes. Metab. 2007, 9, 147–157. [Google Scholar] [CrossRef]
  50. Yang, C.; Chang, T.-J.; Chang, J.-C.; Liu, M.-W.; Tai, T.-Y.; Hsu, W.H.; Chuang, L.-M. Rosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol 3-kinase pathway. Diabetes 2001, 50, 2598–2602. [Google Scholar] [CrossRef] [Green Version]
  51. Chen, K.; Zhao, L.; He, H.; Wan, X.; Wang, F.; Mo, Z. Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway. Int. J. Mol. Med. 2014, 34, 1073–1080. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Li, H.; Zhang, J.; Fu, Y.; Zhang, Y.; Zhang, C.; Sun, X.; Wu, F.; He, J. Antidiabetic compounds 8a, 8b, 8k, and 9h enhance insulin secretion: Activity and mechanism. Endocrine 2020, 1–13. [Google Scholar] [CrossRef]
  53. Kushner, J.A.; Ye, J.; Schubert, M.; Burks, D.J.; Dow, M.A.; Flint, C.L.; Dutta, S.; Wright, C.V.; Montminy, M.R.; White, M.F. Pdx1 restores β cell function in Irs2 knockout mice. J. Clin. Investig. 2002, 109, 1193–1201. [Google Scholar] [CrossRef] [PubMed]
  54. Vetterli, L.M.; Brun, T.; Giovannoni, L.; Bosco, D.; Maechler, P. Resveratrol Potentiates Glucose-stimulated Insulin Secretion in INS-1E β-Cells and Human Islets through a SIRT1-dependent Mechanism. J. Biol. Chem. 2011, 286, 6049–6060. [Google Scholar] [CrossRef] [Green Version]
Biomolecules 11 00279 g001 550
Figure 1. Chemical structures of compounds 1–15 isolated from the flowers of P. persica.
Figure 1. Chemical structures of compounds 1–15 isolated from the flowers of P. persica.
Biomolecules 11 00279 g001
Biomolecules 11 00279 g002 550
Figure 2. Effect of P. persica (PRPE) and compounds 1–15 on the viability of INS-1 cells. Effect of (A) PRPE, (B–P) compounds 1–15 compared with the control (0 μg/mL or 0 μM) on the viability of INS-1 cells for 24 h by 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay (n = 3 independent experiments, p > 0.05, Kruskal–Wallis nonparametric test). Data represent the mean ± SEM.
Figure 2. Effect of P. persica (PRPE) and compounds 1–15 on the viability of INS-1 cells. Effect of (A) PRPE, (B–P) compounds 1–15 compared with the control (0 μg/mL or 0 μM) on the viability of INS-1 cells for 24 h by 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay (n = 3 independent experiments, p > 0.05, Kruskal–Wallis nonparametric test). Data represent the mean ± SEM.
Biomolecules 11 00279 g002
Biomolecules 11 00279 g003 550
Figure 3. Effect of PRPE and compounds 1–15 on glucose-stimulated insulin secretion (GSIS, ng/mL per 400,000 cells) in INS-1 cells. Effect of (A) PRPE, (B–P) compounds 1–15, and (Q) gliclazide (positive control) compared with the control (0 μg/mL or 0 μM) on GSIS (ng/mL per 400,000 cells) in INS-1 cells for 1 h by insulin secretion assay (n = 3 independent experiments, * p > 0.05, Kruskal–Wallis nonparametric test). Data represent the mean ± SEM.
Figure 3. Effect of PRPE and compounds 1–15 on glucose-stimulated insulin secretion (GSIS, ng/mL per 400,000 cells) in INS-1 cells. Effect of (A) PRPE, (B–P) compounds 1–15, and (Q) gliclazide (positive control) compared with the control (0 μg/mL or 0 μM) on GSIS (ng/mL per 400,000 cells) in INS-1 cells for 1 h by insulin secretion assay (n = 3 independent experiments, * p > 0.05, Kruskal–Wallis nonparametric test). Data represent the mean ± SEM.
Biomolecules 11 00279 g003
Biomolecules 11 00279 g004 550
Figure 4. Effect of PRPE and compounds 1–15 on glucose-stimulated insulin secretion (GSIS) expressed as the glucose stimulation index (GSI) in INS-1 cells. Effect of (A) PRPE, (B–P) compounds 1–15, and (Q) gliclazide (positive control) compared with the control (0 μg/mL or 0 μM) on GSIS expressed as the GSI in INS-1 cells for 1 h by insulin secretion assay. GSI = insulin level in high glucose (16.7 mM)/insulin level in low glucose (3.3 mM). (n = 3 independent experiments, * p > 0.05, Kruskal–Wallis nonparametric test). Data represent the mean ± SEM.
Figure 4. Effect of PRPE and compounds 1–15 on glucose-stimulated insulin secretion (GSIS) expressed as the glucose stimulation index (GSI) in INS-1 cells. Effect of (A) PRPE, (B–P) compounds 1–15, and (Q) gliclazide (positive control) compared with the control (0 μg/mL or 0 μM) on GSIS expressed as the GSI in INS-1 cells for 1 h by insulin secretion assay. GSI = insulin level in high glucose (16.7 mM)/insulin level in low glucose (3.3 mM). (n = 3 independent experiments, * p > 0.05, Kruskal–Wallis nonparametric test). Data represent the mean ± SEM.
Biomolecules 11 00279 g004
Biomolecules 11 00279 g005 550
Figure 5. Effect of methyl caffeate (6) on the protein expression levels of peroxisome proliferator activated receptor γ (PPARγ), phospho-insulin receptor substrate-2 (P-IRS-2) (Ser731), IRS-2, phospho-phosphatidylinositol 3-kinase (P-PI3K), PI3K, phospho-Akt (P-Akt) (Ser473), and Akt, and pancreatic and duodenal homeobox-1 (PDX-1) in INS-1 cells. (A) Protein expression levels of P-IRS-2 (Ser731), IRS-2, P-PI3K, PI3K, P-Akt (Ser473), Akt, pancreatic and duodenal homeobox-1 (PDX-1), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in INS-1 cells treated or untreated with 2.5 μM, 5 μM, and 10 μM methyl caffeate (6) for 24 h. (B–F) The bar graph presents the densitometric quantification of Western blot bands (n = 3 independent experiments, * p > 0.05, Kruskal–Wallis nonparametric test). Data represent the mean ± SEM.
Figure 5. Effect of methyl caffeate (6) on the protein expression levels of peroxisome proliferator activated receptor γ (PPARγ), phospho-insulin receptor substrate-2 (P-IRS-2) (Ser731), IRS-2, phospho-phosphatidylinositol 3-kinase (P-PI3K), PI3K, phospho-Akt (P-Akt) (Ser473), and Akt, and pancreatic and duodenal homeobox-1 (PDX-1) in INS-1 cells. (A) Protein expression levels of P-IRS-2 (Ser731), IRS-2, P-PI3K, PI3K, P-Akt (Ser473), Akt, pancreatic and duodenal homeobox-1 (PDX-1), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in INS-1 cells treated or untreated with 2.5 μM, 5 μM, and 10 μM methyl caffeate (6) for 24 h. (B–F) The bar graph presents the densitometric quantification of Western blot bands (n = 3 independent experiments, * p > 0.05, Kruskal–Wallis nonparametric test). Data represent the mean ± SEM.
Biomolecules 11 00279 g005
Table
Table 1. Compounds 1–15 isolated from the flowers of P. persica.
Table 1. Compounds 1–15 isolated from the flowers of P. persica.
NameAmount Obtained (Yield %/Extract)NameAmount Obtained (Yield %/Extract)
Prunasin amide (1) [22]459.8 mg (1.957%)Benzyl α–L-xylpyranosyl-(1→6)-β-glucopyranoside (9) [23]22.7 mg (0.097%)
Amygdalin amide (2) [24]19.6 mg (0.083%)
Prunasin acid (3) [22]99.3 mg (0.423%)Prunin (10) [25]16.7 mg (0.071%)
Mandelamide (4) [24,26]125.6 mg (0.534%)Naringenin (11) [27]15.1 mg (0.064%)
Caffeic acid (5) [28]22.9 mg (0.097%)Nicotiflorin (12) [29]4.3 mg (0.018%)
Methyl caffeate (6) [30]9.0 mg (0.038%)Astragalin (13) [31]17.6 mg (0.075%)
Ferulic acid (7) [32]8.3 mg (0.035%)Afzelin (14) [33]20.9 mg (0.089%)
Chlorogenic acid (8) [34]150.7 mg (0.641%)Uridine (15) [35]10.1 mg (0.043%)
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lee, D.; Qi, Y.; Kim, R.; Song, J.; Kim, H.; Kim, H.Y.; Jang, D.S.; Kang, K.S. Methyl Caffeate Isolated from the Flowers of Prunus persica (L.) Batsch Enhances Glucose-Stimulated Insulin Secretion. Biomolecules 2021, 11, 279. https://doi.org/10.3390/biom11020279

AMA Style

Lee D, Qi Y, Kim R, Song J, Kim H, Kim HY, Jang DS, Kang KS. Methyl Caffeate Isolated from the Flowers of Prunus persica (L.) Batsch Enhances Glucose-Stimulated Insulin Secretion. Biomolecules. 2021; 11(2):279. https://doi.org/10.3390/biom11020279

Chicago/Turabian Style

Lee, Dahae, Yutong Qi, Ranhee Kim, Jungbin Song, Hocheol Kim, Hyun Young Kim, Dae Sik Jang, and Ki Sung Kang. 2021. "Methyl Caffeate Isolated from the Flowers of Prunus persica (L.) Batsch Enhances Glucose-Stimulated Insulin Secretion" Biomolecules 11, no. 2: 279. https://doi.org/10.3390/biom11020279

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop